Treatment of Major Depression with Psychotic Features and Cotard's Syndrome after COVID-19 Infection in a Previously Healthy Patient : A Case Report

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

BACKGROUND: COVID-19 pandemic is related to anxiety, depression, and psychotic symptoms either directly due to invasion or inflammation caused by the virus or indirectly due to related psychosocial stress: fear of infection, social isolation, and financial burden.

CASE PRESENTATION: We present a 28-year-old female case of post-COVID major depression with psychotic features and Cotard's syndrome with no previous psychiatric history. Her complaints initially described the sadness of mood with early morning worsening, diminished interest in almost all activities, anhedonia, increased anxiety, ideas of worthlessness, hopelessness, guilt, decreased sleep, and appetite. Then, she developed severe depression with psychotic features such as delusions of persecution, poverty, and nihilism. Nihilistic delusions included a description of everything coming to an end. She thought that her organs were no more working. Later, she negated her existence and started believing that she was dead. The patient recovered after a combination of sertraline and olanzapine treatment.

CONCLUSION: This case of a COVID-19 patient with psychotic depression and Cotard's delusion highlights the importance of evaluating mental health status and may contribute to our understanding of the potential risk of central nervous system impairment by SARS-CoV-2 infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

CNS & neurological disorders drug targets - 22(2023), 4 vom: 16., Seite 614-617

Sprache:

Englisch

Beteiligte Personen:

Aytac, Hasan Mervan [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Case Reports
Cotard’s syndrome
Depression
Psychotic features
Psychotic symptoms
SARS-CoV-2

Anmerkungen:

Date Completed 16.03.2023

Date Revised 21.03.2023

published: Print

Citation Status MEDLINE

doi:

10.2174/1871527321666220516110620

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341017132